Bath & Body Works, Inc. (NYSE:BBWI) Shares Acquired by Savant Capital LLC

Savant Capital LLC increased its stake in Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) by 6.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,675 shares of the company’s stock after acquiring an additional 552 shares during the quarter. Savant Capital LLC’s holdings in Bath & Body Works were worth $605,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Lone Pine Capital LLC purchased a new position in shares of Bath & Body Works during the third quarter valued at $1,531,646,000. BlackRock Inc. acquired a new position in shares of Bath & Body Works during the 3rd quarter worth about $1,184,238,000. Egerton Capital UK LLP bought a new position in Bath & Body Works during the third quarter valued at about $889,125,000. Steadfast Capital Management LP bought a new position in Bath & Body Works during the third quarter valued at about $468,997,000. Finally, Primecap Management Co. CA bought a new stake in shares of Bath & Body Works in the 3rd quarter valued at approximately $382,655,000. Institutional investors and hedge funds own 92.23% of the company’s stock.

In related news, CFO Wendy C. Arlin sold 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 19th. The stock was sold at an average price of $55.00, for a total value of $330,000.00. Following the completion of the sale, the chief financial officer now directly owns 98,888 shares in the company, valued at $5,438,840. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.37% of the company’s stock.

A number of research firms recently commented on BBWI. Telsey Advisory Group decreased their price target on Bath & Body Works from $91.00 to $70.00 and set an “outperform” rating on the stock in a research report on Thursday, February 24th. Wells Fargo & Company reduced their price objective on Bath & Body Works from $85.00 to $70.00 and set an “overweight” rating on the stock in a report on Tuesday, April 5th. Citigroup reduced their price objective on Bath & Body Works from $100.00 to $93.00 and set a “buy” rating on the stock in a report on Friday, January 7th. Morgan Stanley upped their price objective on Bath & Body Works from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, February 25th. Finally, JPMorgan Chase & Co. reduced their price objective on Bath & Body Works from $105.00 to $81.00 and set an “overweight” rating on the stock in a report on Thursday, February 24th. Three analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $78.89.

NYSE:BBWI opened at $54.10 on Tuesday. The stock’s 50-day simple moving average is $50.31 and its 200 day simple moving average is $61.13. The company has a market cap of $12.90 billion, a P/E ratio of 11.00, a P/E/G ratio of 1.30 and a beta of 1.76. Bath & Body Works, Inc. has a 52-week low of $44.17 and a 52-week high of $82.00.

Bath & Body Works (NYSE:BBWI – Get Rating) last announced its quarterly earnings results on Wednesday, February 23rd. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.03. The firm had revenue of $3.03 billion for the quarter, compared to the consensus estimate of $2.96 billion. Bath & Body Works had a negative return on equity of 115.32% and a net margin of 14.13%. The business’s revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.96 earnings per share. Research analysts anticipate that Bath & Body Works, Inc. will post 4.59 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 4th. Stockholders of record on Friday, February 18th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date was Thursday, February 17th. This is a boost from Bath & Body Works’s previous quarterly dividend of $0.15. Bath & Body Works’s payout ratio is currently 16.26%.

About Bath & Body Works (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Further Reading